Andrew Ward, Rosie Fisher, Lynne Richardson, Jo-Anna Pooler, Sarah Squire, Phil Bates, Rimma Shaposhnikov, Neil Hayward, Milo Thurston, Chris Graham
{"title":"转基因基因中调控印迹和胰岛素样生长因子- ii启动子3活性的基因组区域:新的增强子和沉默子元件","authors":"Andrew Ward, Rosie Fisher, Lynne Richardson, Jo-Anna Pooler, Sarah Squire, Phil Bates, Rimma Shaposhnikov, Neil Hayward, Milo Thurston, Chris Graham","doi":"10.1046/j.1365-4624.1997.00001.x","DOIUrl":null,"url":null,"abstract":"<p>Transgenic lines (89) were made with constructs containing eight different combinations of candidate regulatory elements from the insulin-like growth factor-II (<i>Igf2</i>)–<i>H19</i> region of mouse chromosome 7. In all constructs, promoter 3 of <i>Igf2</i> was attached to a firefly luciferase reporter gene. Promoter 3 was the common element that imposed a decrease in reporter activity similar to that of endogenous <i>Igf2</i> after birth. The specific activity of the reporter was measured on the day of birth in the liver and the brain, after each transgene had been transmitted by either the father or the mother. This procedure demonstrated that the quantity and organ distribution of expression from this promoter can be regulated by each element. The following new information was obtained. (a) The 5′ differentially methylated region of <i>Igf2</i> inhibits promoter 3 in the liver. (b) The conserved DNase I-hypersensitive Middle region between <i>Igf2</i> and <i>H19</i> is an enhancer of promoter 3 in the brain. (c) The <i>H19</i> promoter inhibits <i>Igf2</i> promoter 3 in the brain. The results confirmed that the <i>H19</i> enhancer is a strong enhancer of promoter 3 in the liver. A new finding was that one genomic region regularly imposed imprinted gene expression. This was the <i>H19</i> enhancer, and this region was sufficient to give higher expression on maternal transmission in the majority of transgenic lines. The full data are reported in Supplementary Publication SUP 50180 (8 pages), which has been deposited at the British Library Document Supply Centre, Boston Spa, Wetherby, West Yorkshire LS23 7BQ, U.K., from whom copies can be obtained on the terms indicated in Biochem. J. (1997) <b>21</b>, 8–10.</p>","PeriodicalId":79601,"journal":{"name":"Genes and function","volume":"1 1","pages":"25-36"},"PeriodicalIF":0.0000,"publicationDate":"2008-06-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1046/j.1365-4624.1997.00001.x","citationCount":"20","resultStr":"{\"title\":\"Genomic regions regulating imprinting and insulin-like growth factor-II promoter 3 activity in transgenics: novel enhancer and silencer elements\",\"authors\":\"Andrew Ward, Rosie Fisher, Lynne Richardson, Jo-Anna Pooler, Sarah Squire, Phil Bates, Rimma Shaposhnikov, Neil Hayward, Milo Thurston, Chris Graham\",\"doi\":\"10.1046/j.1365-4624.1997.00001.x\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p>Transgenic lines (89) were made with constructs containing eight different combinations of candidate regulatory elements from the insulin-like growth factor-II (<i>Igf2</i>)–<i>H19</i> region of mouse chromosome 7. In all constructs, promoter 3 of <i>Igf2</i> was attached to a firefly luciferase reporter gene. Promoter 3 was the common element that imposed a decrease in reporter activity similar to that of endogenous <i>Igf2</i> after birth. The specific activity of the reporter was measured on the day of birth in the liver and the brain, after each transgene had been transmitted by either the father or the mother. This procedure demonstrated that the quantity and organ distribution of expression from this promoter can be regulated by each element. The following new information was obtained. (a) The 5′ differentially methylated region of <i>Igf2</i> inhibits promoter 3 in the liver. (b) The conserved DNase I-hypersensitive Middle region between <i>Igf2</i> and <i>H19</i> is an enhancer of promoter 3 in the brain. (c) The <i>H19</i> promoter inhibits <i>Igf2</i> promoter 3 in the brain. The results confirmed that the <i>H19</i> enhancer is a strong enhancer of promoter 3 in the liver. A new finding was that one genomic region regularly imposed imprinted gene expression. This was the <i>H19</i> enhancer, and this region was sufficient to give higher expression on maternal transmission in the majority of transgenic lines. The full data are reported in Supplementary Publication SUP 50180 (8 pages), which has been deposited at the British Library Document Supply Centre, Boston Spa, Wetherby, West Yorkshire LS23 7BQ, U.K., from whom copies can be obtained on the terms indicated in Biochem. J. (1997) <b>21</b>, 8–10.</p>\",\"PeriodicalId\":79601,\"journal\":{\"name\":\"Genes and function\",\"volume\":\"1 1\",\"pages\":\"25-36\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2008-06-28\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://sci-hub-pdf.com/10.1046/j.1365-4624.1997.00001.x\",\"citationCount\":\"20\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Genes and function\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://onlinelibrary.wiley.com/doi/10.1046/j.1365-4624.1997.00001.x\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Genes and function","FirstCategoryId":"1085","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1046/j.1365-4624.1997.00001.x","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 20
摘要
89个转基因品系含有小鼠7号染色体胰岛素样生长因子- ii (Igf2) -H19区候选调控元件的8种不同组合。在所有构建中,Igf2的启动子3都连接到萤火虫荧光素酶报告基因上。启动子3是导致报告基因活性下降的共同因素,类似于出生后内源性Igf2的下降。报告基因的具体活性是在出生当天在肝脏和大脑中测量的,在每个转基因被父亲或母亲传播之后。该过程表明,该启动子的表达量和器官分布可以由每个元件调节。获得了以下新信息。(a)肝脏中Igf2的5 '差异甲基化区抑制启动子3。(b) Igf2和H19之间保守的dna酶i敏感的中间区域是大脑启动子3的增强子。(c)脑中H19启动子抑制Igf2启动子3。结果证实H19增强子是肝脏启动子3的强增强子。一项新的发现是,一个基因组区域有规律地施加了印迹基因表达。这是H19增强子,在大多数转基因系中,该区域足以在母系传播中获得较高的表达。完整的数据报告在补充出版物SUP 50180(8页)中,该出版物已存放在英国西约克郡LS23 7BQ, Boston Spa, Wetherby, British Library Document Supply Centre,从那里可以根据Biochem中指出的条款获得副本。[j](1997) 21, 8-10。
Genomic regions regulating imprinting and insulin-like growth factor-II promoter 3 activity in transgenics: novel enhancer and silencer elements
Transgenic lines (89) were made with constructs containing eight different combinations of candidate regulatory elements from the insulin-like growth factor-II (Igf2)–H19 region of mouse chromosome 7. In all constructs, promoter 3 of Igf2 was attached to a firefly luciferase reporter gene. Promoter 3 was the common element that imposed a decrease in reporter activity similar to that of endogenous Igf2 after birth. The specific activity of the reporter was measured on the day of birth in the liver and the brain, after each transgene had been transmitted by either the father or the mother. This procedure demonstrated that the quantity and organ distribution of expression from this promoter can be regulated by each element. The following new information was obtained. (a) The 5′ differentially methylated region of Igf2 inhibits promoter 3 in the liver. (b) The conserved DNase I-hypersensitive Middle region between Igf2 and H19 is an enhancer of promoter 3 in the brain. (c) The H19 promoter inhibits Igf2 promoter 3 in the brain. The results confirmed that the H19 enhancer is a strong enhancer of promoter 3 in the liver. A new finding was that one genomic region regularly imposed imprinted gene expression. This was the H19 enhancer, and this region was sufficient to give higher expression on maternal transmission in the majority of transgenic lines. The full data are reported in Supplementary Publication SUP 50180 (8 pages), which has been deposited at the British Library Document Supply Centre, Boston Spa, Wetherby, West Yorkshire LS23 7BQ, U.K., from whom copies can be obtained on the terms indicated in Biochem. J. (1997) 21, 8–10.